OmniAb Inc
NASDAQ:OABI
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
US |
O
|
OmniAb Inc
NASDAQ:OABI
|
509.5m USD | -5.3 | |
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
216.8B USD | 32.8 | ||
US |
Danaher Corp
NYSE:DHR
|
190.2B USD | 21.1 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
39.9B USD | 24.4 | ||
US |
Agilent Technologies Inc
NYSE:A
|
38.2B USD | 29.8 | ||
CH |
Lonza Group AG
SIX:LONN
|
35.1B CHF | 27.1 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
52T KRW | 44.4 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
30B USD | 29.3 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.9B USD | 27.2 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
24.2B USD | 35.8 | ||
US |
Waters Corp
NYSE:WAT
|
18.3B USD | 25.4 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.